Propanc reports preclinical pancreatic cancer data for PRP drug candidate

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Propanc reports preclinical pancreatic cancer data for PRP drug candidate
(NASDAQ: PPCB) Delayed: 0.63 -0.01 (1.56%)
Previous Close $0.64    52 Week High $ 
Open $0.64    52 Week Low $ 
Day High $0.73    P/E N/A 
Day Low $0.63    EPS $ 
Volume 449,798